New treatment for recurrence of C. difficile infection approved by FDA
by Liam Connolly,UC DavisCredit: Pixabay/CC0 Public DomainThe U.S. Food and Drug Administration (FDA) has approved VOWST, a microbiota-based therapeutic to prevent recurrence of C. difficile Inf
Updated on: February 21,2024
20

New treatment for recurrence of C. difficile infection approved by FDA
by Liam Connolly,UC DavisCredit: Pixabay/CC0 Public DomainThe U.S. Food and Drug Administration (FDA) has approved VOWST, a microbiota-based therapeutic to prevent recurrence of C. difficile Inf
Updated on:February 21,2024
20
